[
  {
    "ts": null,
    "headline": "Insulet Corp. stock underperforms Thursday when compared to competitors",
    "summary": "Insulet Corp. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=ad2203063e25368b7edf6ddf41aa65ce9e2daf42ba0a3e9e7b1e14439873be77",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740676200,
      "headline": "Insulet Corp. stock underperforms Thursday when compared to competitors",
      "id": 132922601,
      "image": "",
      "related": "PODD",
      "source": "MarketWatch",
      "summary": "Insulet Corp. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=ad2203063e25368b7edf6ddf41aa65ce9e2daf42ba0a3e9e7b1e14439873be77"
    }
  },
  {
    "ts": null,
    "headline": "Tandem’s insulin pump tech wins FDA nod for Type 2 diabetes",
    "summary": "Tandem is following competitor Insulet’s lead with the second automated insulin delivery system indicated for Type 2 diabetes.",
    "url": "https://finnhub.io/api/news?id=8041b5b77e5c96f05f0b6485dd59ca5bbc04991780f5f1c9304c6955998f835f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740656959,
      "headline": "Tandem’s insulin pump tech wins FDA nod for Type 2 diabetes",
      "id": 133192089,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "Tandem is following competitor Insulet’s lead with the second automated insulin delivery system indicated for Type 2 diabetes.",
      "url": "https://finnhub.io/api/news?id=8041b5b77e5c96f05f0b6485dd59ca5bbc04991780f5f1c9304c6955998f835f"
    }
  },
  {
    "ts": null,
    "headline": "Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)",
    "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom (NASDAQ:DXCM).",
    "url": "https://finnhub.io/api/news?id=3e48d2d18049e1e358b275c7e2198e3164b6e899ea097ca582385560baa35738",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740647109,
      "headline": "Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)",
      "id": 133190180,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom (NASDAQ:DXCM).",
      "url": "https://finnhub.io/api/news?id=3e48d2d18049e1e358b275c7e2198e3164b6e899ea097ca582385560baa35738"
    }
  }
]